XM does not provide services to residents of the United States of America.
C
C

Capgemini

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

French and Benelux stocks-Factors to watch

French and Benelux stocks-Factors to watch July 4 (Reuters) - Below are company-related news and stories from France and Benelux which could have an impact on the region's markets or individual stocks. PLUXEE PLX.PA : The French voucher and benefits firm upgraded its full-year organic revenue growth guidance after strong third-quarter growth driven by Latin America.
C
F
N
U

EQT’s $3 bln gaming play hits the right buttons

BREAKINGVIEWS-EQT’s $3 bln gaming play hits the right buttons The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Oliver Taslic LONDON, July 3 (Reuters Breakingviews) - EQT EQTAB.ST has found a solid strategy for investing in the unreliable gaming market. The Swedish buyout shop is splurging 2.1 billion pounds on Keywords Studios KWS.L , a business that services game designers like Nintendo 7974.T .
C
E
T

Capgemini Completes Acquisition Of Lösch & Partner

BRIEF-Capgemini Completes Acquisition Of Lösch & Partner July 1 (Reuters) - Capgemini SE CAPP.PA : CAPGEMINI TO ACQUIRE LÖSCH & PARTNER TRANSACTION CLOSED ON JUNE 28, 2024 Source text: https://tinyurl.com/cbmrj73v Further company coverage: CAPP.PA (Gdansk Newsroom)
C

Capgemini Signs Agreement With AJ Vaccines To Create New Business Platform

BRIEF-Capgemini Signs Agreement With AJ Vaccines To Create New Business Platform June 26 (Reuters) - Capgemini SE CAPP.PA : SAID ON TUESDAY: SIGNS AGREEMENT WITH DANISH VACCINE PRODUCER AJ VACCINES DEAL TO ENABLE AJ VACCINES' COMPREHENSIVE DIGITAL TRANSFORMATION CAPGEMINI WILL CREATE A NEW BUSINESS PLATFORM TO ENHANCE OPERATIONAL EFFICIENCY AND AGI
C

Capgemini Signs Agreement To Acquire D+I In Australia

BRIEF-Capgemini Signs Agreement To Acquire D+I In Australia June 25 (Reuters) - Capgemini SE CAPP.PA : SIGNS AGREEMENT TO ACQUIRE AUSTRALIAN PRODUCT DESIGN AND DEVELOPMENT CONSULTANCY FIRM D+I TRANSACTION IS DUE TO CLOSE IN THE COMING MONTHS DEAL SUBJECT TO REGULATORY APPROVAL AND OTHER CUSTOMARY CONDITIONS Source text for Workspace: ID:nNDL5fzymd
C

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.